The Court of Justice of the European Union has issued its long-awaited judgement on the interpretation of Articles 3(a) and (c) of the SPC Regulation in the joined cases C-119/22 and C-149/22.
The European AI Office is currently facilitating the drawing-up of the General-Purpose AI Code of Practice. The European Commission published the first draft of the Code on 14 November 2024. Further drafts are to be prepared, with the final version of the Code forecast to be released by 2 May 2025, in accordance with Article 56 (Codes of Practice) of the EU AI Act.
The Ideas Powered for Business SME Fund is a grant scheme designed to assist EU-based small and medium-sized enterprises in protecting their intellectual property rights.
In recent years, the convergence of beauty and pharmaceuticals has given rise to a new category of skincare products: cosmeceuticals. Cosmeceuticals blend cosmetic and pharmaceutical benefits and are designed to address skin complaints such as acne, dermatitis, and signs of aging.
In the competitive world of cosmetics, the secret to standing out lies not just in your cosmetic formulations but also in your packaging.
The CJEU has handled the Hungarian referral in case C-181/24 with a straightforward confirmation that an application for a SPC must be based on the first marketing authorisation for the product.
If your next invention is going to have the commercial impact it should, you will need to correctly identify, protect, exploit, and enforce it. This is exactly what Potter Clarkson’s patent attorneys in Copenhagen do.
The Supreme Administrative Court in the Czech Republic has asked the CJEU whether a substance classified as an excipient in a marketing authorisation can still be considered an active ingredient for an SPC application, and what information is needed for an additional active ingredient to be "specifically identifiable" based on the patent.
We are delighted to report that our client, Proteotype Diagnostics Ltd, has just been awarded a £1.5 million Cancer Mission Grant to advance the groundbreaking work they have been doing in early cancer detection with their innovative Enlighten™ test.
A preliminary view (G 1/23) from the European Patent Office may push technology businesses in all fields to re-evaluate their commercial planning and IP strategies.
Let’s delve deeper into the many applications relating to seaweed which are sculpting the patent landscape.
The EU Commission published four proposals for amending the current regime for Supplementary Protection Certificates (SPCs) to enable a centralised examination of national and unitary SPCs. We summarise the proposals and some aspects of concern.
On 30 June 2023 the US District Court for the District of New Jersey ruled in favour of Orexo AB in its patent litigation against Sun in relation to ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), with the Court ruling that Orexo’s patents are both valid and are infringed by Sun.
The Society of Chemical Industries (SCI) has just launched its manifesto for an Industrial Science & Innovation Strategy.
The House of Lords Sub-Committee on the Protocol on Ireland/Northern Ireland released its report on the Windsor Framework on 25 July 2023. In case you missed it, we summarise below how the Framework will affect the valuable intellectual property rights known as Supplementary Protection Certificates (SPCs) in the UK.